Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy

被引:44
作者
Tschirdewahn, Stephan [1 ]
Wiesenfarth, Manuel [2 ]
Bonekamp, David [3 ]
Puellen, Lukas [1 ]
Reis, Henning [4 ]
Panic, Andrej [1 ]
Kesch, Claudia [1 ]
Darr, Christopher [1 ]
Hess, Jochen [1 ]
Giganti, Francesco [5 ,6 ]
Moore, Caroline M. [6 ,7 ]
Guberina, Nika [8 ]
Forsting, Michael [8 ]
Wetter, Axel [8 ]
Hadaschik, Boris [1 ]
Radtke, Jan Philipp [1 ,3 ]
机构
[1] Univ Hosp Essen, Dept Urol, Hufelandstr 55, D-45147 Essen, Germany
[2] German Canc Res Ctr, Div Biostat, Heidelberg, Germany
[3] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany
[4] Univ Duisburg Essen, Inst Pathol, Essen, Germany
[5] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England
[6] UCL, Div Surg & Intervent Sci, London, England
[7] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England
[8] Univ Hosp Essen, Inst Diagnost & Intervent Radiol, Essen, Germany
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Prostate cancer; Magnetic resonance imaging; Targeted biopsy; Target saturation; transrectal ultrasound fusion; Detection accuracy of target; saturation biopsy; DIAGNOSTIC-ACCURACY; MRI;
D O I
10.1016/j.euf.2020.06.020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsies (TBs) facilitate accurate detection of significant prostate cancer (sPC). However, it remains unclear how many cores should be applied per target. Objective: To assess sPC detection rates of two different target-dependent magnetic resonance imaging (MRI)/transrectal ultrasonography (TRUS)-fusion biopsy approaches (TB and target saturation [TS]) compared with extended systematic biopsies (SBs). Design, setting, and participants: Retrospective single-centre outcome of transperineal MRI/TRUS-fusion biopsies of 213 men was evaluated. All men underwent TB with a median of four cores per MRI lesion, followed by a median of 24 SBs, performed by experienced urologists. Cancer and sPC (International Society of Urological Pathology grade group 2) detection rates were analysed. TB was compared with SB and TS, with nine cores per target, calculated by the Ginsburg scheme and using individual cores of the lesion and its "penumbra". Outcome measurements and statistical analysis: Cancer detection rates were calculated for TS, TB, and SB at both lesion and patient level. Combination of SB + TB served as a reference. Statistical differences in prostate cancer (PC) detection between groups were calculated using McNemar's tests with confidence intervals. Results and limitations: TS detected 99% of 134 sPC lesions, which was significantly higher than the detection by TB (87%, p = 0.001) and SB (82%, p < 0.001). SB detected significantly more of the 72 low-risk PC lesions than TB (99% vs 68%, p < 0.001) and 10% (p = 0.15) more than that detected by TS. At a per-patient level, 99% of men harbouring sPC were detected by TS. This was significantly higher than that by TB and SB (89%, p = 0.03 and 81%, p = 0.001, respectively). Limitations include limited generalisability, as a transperineal biopsy route was used.
引用
收藏
页码:1300 / 1307
页数:8
相关论文
共 50 条
  • [41] The Comparison of Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsies with Conventional Transrectal Biopsies in Prostate Cancer Detection
    Baba, Dursun
    Balik, Ahmet Yildirim
    Yuksel, Alpaslan
    Senoglu, Yusuf
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2021, 20 (04): : 210 - 214
  • [42] Added values of transrectal ultrasonography to magnetic resonance imaging in characterizing prostate cancer
    Park, Byung Kwan
    [J]. PRECISION AND FUTURE MEDICINE, 2023, 7 (03): : 131 - 135
  • [43] Detection of prostate cancer using magnetic resonance imaging/ultrasonography image-fusion targeted biopsy in African-American men
    Shin, Toshitaka
    Smyth, Thomas B.
    Ukimura, Osamu
    Ahmadi, Nariman
    Abreu, Andre Luis de Castro
    Oishi, Masakatsu
    Mimata, Hiromitsu
    Gill, Inderbir S.
    [J]. BJU INTERNATIONAL, 2017, 120 (02) : 233 - 238
  • [44] Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy
    Muthigi, Akhil
    George, Arvin K.
    Sidana, Abhinav
    Kongnyuy, Michael
    Simon, Richard
    Moreno, Vanessa
    Merino, Maria J.
    Choyke, Peter L.
    Turkbey, Baris
    Wood, Bradford J.
    Pinto, Peter A.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (02) : 327 - 333
  • [45] Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy
    Borkowetz, Angelika
    Platzek, Ivan
    Toma, Marieta
    Renner, Theresa
    Herout, Roman
    Baunacke, Martin
    Laniado, Michael
    Baretton, Gustavo
    Froehner, Michael
    Zastrow, Stefan
    Wirth, Manfred
    [J]. BJU INTERNATIONAL, 2016, 118 (02) : 213 - 220
  • [46] Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer
    Ridout, Ashley J.
    Kasivisvanathan, Veeru
    Emberton, Mark
    Moore, Caroline M.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 5 - 11
  • [47] Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
    Song, Byeongdo
    Hwang, Sung Il
    Lee, Hak Jong
    Jeong, Seong Jin
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sangchul
    [J]. MEDICINE, 2022, 101 (40) : E30821
  • [48] Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy
    Lenfant, Louis
    Beitone, Clement
    Troccaz, Jocelyne
    Beaugerie, Aurelien
    Roupret, Morgan
    Seisen, Thomas
    Renard-Penna, Raphaele
    Voros, Sandrine
    Mozer, Pierre C.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 430 - 437
  • [49] Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy
    van de Ven, Wendy J. M.
    Sedelaar, J. P. Michiel
    van der Leest, Marloes M. G.
    Hulsbergen-van de Kaa, Christina A.
    Barentsz, Jelle O.
    Futterer, Jurgen J.
    Huisman, Henkjan J.
    [J]. CLINICAL IMAGING, 2016, 40 (04) : 745 - 750
  • [50] Target detection: Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy
    Sonn, Geoffrey A.
    Margolis, Daniel J.
    Marks, Leonard S.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (06) : 903 - 911